Cell cycle deregulation in neurodegenerative diseases

References

• Klein JA, Longo-Guess CM, Rossmann MP, et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 2002;419(6905):367–374.
   PubMed Web of Science ®Google Scholar
• Klein JA, Ackerman SL. Oxidative stress, cell cycle, and neurodegeneration. J Clin Invest. 2003;111(6):785–793.
   PubMed Web of Science ®Google Scholar
• Vincent I, Jicha G, Rosado M, et al. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain. J Neurosci. 1997;17(10):3588–3598.
   PubMed Web of Science ®Google Scholar
• Hradek AC, Lee HP, Siedlak SL, et al. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer’s disease patients. JAD. 2014;43(1):57–65.
   Web of Science ®Google Scholar
• Williams GH, Stoeber K. The cell cycle and cancer. J Pathol. 2012;226(2):352–364.
   PubMed Web of Science ®Google Scholar
• Chen MJ, Ng JM, Peng ZF, et al. Gene profiling identifies commonalities in neuronal pathways in excitotoxicity: evidence favouring cell cycle re-activation in concert with oxidative stress. Neurochem Int. 2013;62(5):719–730.
   PubMed Web of Science ®Google Scholar
• Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology. 2002;181–182:475–481.
   PubMed Web of Science ®Google Scholar
• Nishitani H, Lygerou Z. Control of DNA replication licensing in a cell cycle. Genes Cells. 2002;7(6):523–534.
   PubMed Web of Science ®Google Scholar
• Fischer PM, Endicott J, Meijer L. Cyclin-dependent kinase inhibitors. Prog Cell Cycle Res. 2003;5:235–248.
   PubMedGoogle Scholar
• Bashari D, Hacohen D, Ginsberg D. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis. Cell Signal. 2011;23(1):65–70.
   PubMed Web of Science ®Google Scholar
• Manchado E, Eguren M, Malumbres M. The anaphase-promoting complex/cyclosome (APC/C): cell-cycle-dependent and -independent functions. Biochem Soc Trans. 2010;38(1):65–71.
   PubMed Web of Science ®Google Scholar
• Kannan M, Lee SJ, Schwedhelm-Domeyer N, et al. p250GAP is a novel player in the Cdh1-APC/Smurf1 pathway of axon growth regulation. PLoS One. 2012;7(11):e50735.
   PubMed Web of Science ®Google Scholar
• Almeida A. Regulation of APC/C-Cdh1 and its function in neuronal survival. Mol Neurobiol. 2012;46(3):547–554.
   PubMed Web of Science ®Google Scholar
• Yao W, Qian W, Zhu C, et al. Cdh1-APC is involved in the differentiation of neural stem cells into neurons. Neuroreport. 2010;21(1):39–44.
   PubMed Web of Science ®Google Scholar
• Elias J, Dimitrio L, Clairambault J, et al. The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate. Biochim Biophys Acta. 2014;1844(1):232–247.
   PubMed Web of Science ®Google Scholar
• Eguren M, Manchado E, Malumbres M. Non-mitotic functions of the Anaphase-Promoting Complex. Semin Cell Dev Biol. 2011;22(6):572–578.
   PubMed Web of Science ®Google Scholar
• Dai Y, Grant S. Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents. Curr Oncol Rep. 2004;6(2):123–130.
   PubMedGoogle Scholar
• Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron. 2003;39(6):889–909.
   PubMed Web of Science ®Google Scholar
• Shakya A, Cooksey R, Cox JE, et al. Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity. Nat Cell Biol. 2009;11(3):320–327.
   PubMed Web of Science ®Google Scholar
• Hernandez-Ortega K, Quiroz-Baez R, Arias C. Cell cycle reactivation in mature neurons: a link with brain plasticity, neuronal injury and neurodegenerative diseases?Neurosci Bull. 2011;27(3):185–196.
   PubMed Web of Science ®Google Scholar
• Malik B, Currais A, Andres A, et al. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer’s disease brain. Cell Cycle. 2008;7(5):637–646.
   PubMed Web of Science ®Google Scholar
• Absalon S, Kochanek DM, Raghavan V, et al. MiR-26b, upregulated in Alzheimer’s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons. J Neurosci. 2013;33(37):14645–14659.
   PubMed Web of Science ®Google Scholar
• Zekanowski C, Wojda U. Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer’s disease. Acta Neurobiol Exp (Wars). 2009;69(2):232–253.
   PubMed Web of Science ®Google Scholar
• Saad O, Carine J, NoeL G. “Till Death Do Us Part”: a potential irreversible link between aberrant cell cycle control and neurodegeneration in the adult olfactory bulb. Front Neurosci. 2018;12:144.
   PubMed Web of Science ®Google Scholar
• Esteras N, Alquézar C, Bartolomé F, et al. G1/S cell cycle checkpoint dysfunction in lymphoblasts from sporadic parkinson’s disease patients. Mol Neurobiol. 2015;52(1):386–398.
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Bowser R. Alterations in G1 to S phase cell cycle regulators during amyotrophic lateral sclerosis. Am J Pathol. 2003;162(3):823–835.
   PubMed Web of Science ®Google Scholar
• Bhaskar K, Miller M, Chludzinski A, et al. The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol Neurodegener. 2009;4(1):14–31.
   PubMed Web of Science ®Google Scholar
• Park DS, Morris EJ, Padmanabhan J, et al. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol. 1998;143(2):457–467.
   PubMed Web of Science ®Google Scholar
• Dubinina EE, Schedrina LV, Neznanov NG, et al. Oxidative stress and its effect on cells functional activity of alzheimer’s disease. Biomed Khim. 2015;61(1):57–69.
   PubMedGoogle Scholar
• Verdaguer E, Garcia-Jorda E, Canudas AM, et al. Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. Neuroreport. 2002;13(4):413–416.
   PubMed Web of Science ®Google Scholar
• Barrio-Alonso E, et al. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci Rep. 2018;8:14316. 
   PubMed Web of Science ®Google Scholar
• McShea A, Lee HG, Petersen RB, et al. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta. 2007;1772(4):467–472.
   PubMed Web of Science ®Google Scholar
• Schmetsdorf S, Arnold E, Holzer M, et al. A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur J Neurosci. 2009;29(6):1096–1107.
   PubMed Web of Science ®Google Scholar
• Yang Y, Varvel NH, Lamb BT, et al. Ectopic cell cycle events link human Alzheimer’s disease and amyloid precursor protein transgenic mouse models. J Neurosci. 2006;26(3):775–784.
   PubMed Web of Science ®Google Scholar
• Thakur A, Siedlak SL, James SL, et al. Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. Int J Clin Exp Pathol. 2008;1:134–146.
   PubMed Web of Science ®Google Scholar
• Almeida A, Bolanos JP, Moreno S. Cdh1/Hct1-APC is essential for the survival of postmitotic neurons. J Neurosci. 2005;25(36):8115–8121.
   PubMed Web of Science ®Google Scholar
• Liu DY, Zhang L. MicroRNA-132 promotes neurons cell apoptosis and activates Tau phosphorylation by targeting GTDC-1 in Alzheimer’s disease. Eur Rev Med Pharmacol Sci. 2019;23(19):8523–8532.
   PubMed Web of Science ®Google Scholar
• Chu T, Shu Y, Qu Y, et al. miR-26b inhibits total neurite outgrowth, promotes cells apoptosis and downregulates neprilysin in Alzheimer’s disease. Int J Clin Exp Path. 2018;11(7):3383–3390.
   PubMed Web of Science ®Google Scholar
• Arendt T, Holzer M, Gartner U. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer’s disease. J Neural Transm (Vienna). 1998;105(8–9):949–960.
   PubMed Web of Science ®Google Scholar
• Arendt T, Rodel L, Gartner U, et al. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer’s disease. Neuroreport. 1996;7:3047–3049.
   PubMed Web of Science ®Google Scholar
• Silva AR, Santos AC, Farfel JM, et al. Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer’s disease. PLoS One. 2014;9(6):e99897.
   PubMed Web of Science ®Google Scholar
• Yates SC, Zafar A, Rabai EM, et al. The effects of two polymorphisms on p21cip1 function and their association with Alzheimer’s disease in a population of European descent. PLoS One. 2015;10(1):e114050.
   Web of Science ®Google Scholar
• Patrick GN, Zukerberg L, Nikolic M, et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999;402(6762):615–622. [10604467]
   PubMed Web of Science ®Google Scholar
• Zhou J, Li H, Li X, et al. The roles of Cdk5-mediated subcellular localization of FOXO1 in neuronal death. J Neurosci. 2015;35(6):2624–2635.
   PubMed Web of Science ®Google Scholar
• Wen Y, Yu WH, Maloney B, et al. Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron. 2008;57(5):680–690. [18341989]
   PubMed Web of Science ®Google Scholar
• Shen LL, Li WW, Xu YL, et al. Neurotrophin receptor p75 mediates amyloid beta-induced tau pathology. Neurobiol Dis. 2019;132:104567.
   PubMed Web of Science ®Google Scholar
• Huang F, Wang M, Liu R, et al. CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer’s disease. Alzhmer’s Dement. 2018;15(2):217–231.
   PubMed Web of Science ®Google Scholar
• Huang Y, Huang W, Huang Y, et al. Cdk5 inhibitory peptide prevents loss of neurons and alleviates behavioral changes in p25 transgenic mice. J Alzheimers Dis. 2020;74(4):1231–1242.
   PubMed Web of Science ®Google Scholar
• Hoon LK, Sei-Jung L, Jik LH, et al. Amyloid β1-42 (Aβ1-42) induces the CDK2-mediated phosphorylation of tau through the activation of the mTORC1 signaling pathway while promoting neuronal cell death. Front Mol Neurosci. 2017;10:229.
   PubMed Web of Science ®Google Scholar
• Furuya T, Kim M, Lipinski M, et al. Negative regulation of Vps34 by Cdk mediated phosphorylation. Mol Cell. 2010;38(4):500–511. [20513426]
   PubMed Web of Science ®Google Scholar
• Przedborski S, Jackson-Lewis V, Naini AB, et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem. 2001;76(5):1265–1274.
   PubMed Web of Science ®Google Scholar
• Jenner P, Olanow CW. Understanding cell death in Parkinson’s disease. Ann Neurol. 1998;44:S72–S84.
   PubMed Web of Science ®Google Scholar
• Hoglinger GU, Breunig JJ, Depboylu C, et al. The pRb/E2F cell-cycle pathway mediates cell death in Parkinson’s disease. Proc Natl Acad Sci U S A. 2007;104(9):3585–3590.
   PubMed Web of Science ®Google Scholar
• Smith PD, Crocker SJ, Jackson-Lewis V, et al. Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson’s ­disease. Proc Natl Acad Sci U S A. 2003;100(23):13650–13655.
   PubMed Web of Science ®Google Scholar
• Wong ASL, Lee RHK, Cheung AY, et al. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson’s disease. Nat Cell Biol. 2011;13(5):568–579. [21499257]
   PubMed Web of Science ®Google Scholar
• Hongcai W, Yan C, Jinbo C, et al. Cell cycle regulation of DNA polymerase beta in rotenone-based parkinson’s disease models. PLoS One. 2014;9(10):e109697.
   PubMed Web of Science ®Google Scholar
• El-Khodor BF, Oo TF, Kholodilov N, et al. Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta. Exp Neurol. 2003;179(1):17–27.
   PubMed Web of Science ®Google Scholar
• Wen Z, Shu Y, Gao C, et al. CDK5-mediated phosphorylation and autophagy of RKIP regulate neuronal death in Parkinson’s disease. Neurobiol Aging. 2014;35(12):2870–2880.
   PubMed Web of Science ®Google Scholar
• Pan H, Yin C, Dyson NJ, et al. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell. 1998;2(3):283–292.
   PubMed Web of Science ®Google Scholar
• Jordan-Sciutto KL, Dorsey R, Chalovich EM, et al. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol. 2003;62(1):68–74.
   PubMed Web of Science ®Google Scholar
• Chen Y, Hou Y, Ge R, et al. Protective effect of roscovitine against rotenone-induced parkinsonism. Restor Neurol Neurosci. 2018;36:629–638.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Blanco J, Martin V, Herrera F, et al. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine. J Neurochem. 2008;107(1):127–140.
   PubMed Web of Science ®Google Scholar
• Gallastegui E, Domuro C, Serratosa J, et al. p27 Kip1 regulates alpha-synuclein expression. Oncotarget. 2018;9(23):16368–16379.
   PubMedGoogle Scholar
• Sasaki T, Mochizuki H. Neuroprotective effects of Necdin in the Parkinson’s disease. Nihon Rinsho. 2017;75(1):36–41.
   PubMedGoogle Scholar
• Bajaj NPS, Al-Sarraj ST, Leigh PN, et al. Cyclin dependent kinase-5 (CDK-5) phosphorylates neurofilament heavy (NF-H) chain to generate epitopes for antibodies that label neurofilament accumulations in amyotrophic lateral sclerosis (ALS) and is present in affected motor neurones in ALS. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23(5):833–850. [10509378]
   PubMed Web of Science ®Google Scholar
• Nguyen MD, Boudreau M, Kriz J, et al. Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1. J Neurosci. 2003;23(6):2131–2140.
   PubMed Web of Science ®Google Scholar
• Yujiao Y, Tadashi N, Akane M, et al. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. Hum Mol Genet. 2019;20:20.
   Google Scholar
• Appert-Collin A, Hugel B, Levy R, et al. Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons. Life Sci. 2006;79(5):484–490.
   PubMed Web of Science ®Google Scholar
• Binukumar BK, Skuntz S, Prochazkova M, et al. Overexpression of the Cdk5 inhibitory peptide in motor neurons rescue of amyotrophic lateral sclerosis phenotype in a mouse model. Hum Mol Genet. 2019:28(19):3175–3187.
   PubMed Web of Science ®Google Scholar
• Cova E, Ghiroldi A, Guareschi S, et al. G93A SOD1 alters cell cycle in a cellular model of Amyotrophic Lateral Sclerosis. Cell Signal. 2010;22(10):1477–1484.
   PubMed Web of Science ®Google Scholar